NEW YORK, Sept. 21, 2016 /PRNewswire/ -- Dermatology is a branch of medical science that deals with examination and treatment of various disorders and diseases related to the skin, hair, nails, including its surgical aspect. The stakeholders of this market report comprise established original equipment and pharmaceutical product manufacturers, product distributors, and new players who wish to enter the global dermatology diagnostic devices and therapeutics market.
This report provides a complete analysis of the global dermatology diagnostic devices and therapeutics market and helps in recognizing several governing factors that impact the market both positively and negatively. Executive summary of the report captures comprehensive insights about every segment considered in this study. It includes a market snapshot offering an insight into the current scenario of the dermatology diagnostic device and dermatology market in terms of current and future market size along with growth rate.
The market overview segment provides thorough information on the trends in the usage pattern of various diagnostic devices and therapeutics for dermatology, such as drivers, restraints, and growth opportunities that presently regulate the dynamics of the overall market. Competitive analysis tools such as Porter's Five Forces analysis and market attractiveness analysis have also been incorporated in this study to provide analysis about the level of competition within the dermatology diagnostic devices and therapeutics market. Competitive intelligence tools such as market attractiveness analysis have also been included in the market overview section of the report to deliver a clear understanding of the most attractive and fastest growing device segment, drug class and region globally for dermatology diagnostic devices and therapeutics.
Market share analysis thus provided in this study is in context with major players of dermatology diagnostic devices and dermatology therapeutics operating in the market; this would help new players to understand the key business models and geographical presence and identify the specific product lines of existing companies to establish a strong presence in the dermatology diagnostic devices and therapeutics market. Furthermore, the research comprises a chapter on pipeline analysis for this industry that includes tabular representation of phase I and phase II candidates along with sales forecast potential drugs that are undergoing phase III clinical trials and are expected to be marketed during the forecast period.
The global dermatology diagnostic devices and therapeutics market has been segmented based on various dermatology diagnostic devices, drug classes used for treating dermatology disorders, and geographies. Based on dermatology diagnostic products the market has been categorized into dermatoscopes, microscopes & trichoscopes, and imaging equipment. Based on drug class the dermatology therapeutics market has been segmented into antibacterials, antifungal agents, antiviral agents, corticosteroids, retinoids, immunosuppresants, biologics. The market size for the period from 2013 to 2023 has been provided for each of the devices and therapeutics categories mentioned above in terms of US$ Mn. Along with the market size that was projected considering 2014 as the base year and 2013 as the historical year, the CAGR (%) of each market segment for the forecast period from 2015 to 2023 (for therapeutics forecast period is from 2013 to 2018 and 2018 to 2023) has also been provided.
Geographically, the dermatology diagnostic devices and therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & North Africa, and Rest of the World. North America has been further segmented into the U.S. and Canada; Europe into Germany, the U.K. and Rest of Europe; Asia Pacific into China, Japan, India, Australia, and Rest of Asia Pacific; Latin America into Brazil and Rest of Latin America; Middle East & North Africa (MENA) into Egypt, Kuwait, UAE, Saudi Arabia, and rest of MENA; and Rest of the world. The market revenue of dermatology diagnostic devices and therapeutics for each geographical region for 2014 and 2023 along with forecast from 2015 to 2023 in respective regions in terms of USD Mn, has been explained in the geography section of the report.
This market study concludes with profiles of key players in the global dermatology diagnostic devices and dermatology market. The report summarizes the companies in terms of overview, financial overview, product and services portfolio, key business strategies, and recent developments. The major players profiled in the section are Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech, a Roche Company, GlaxoSmithKline plc (Stiefel Laboratories, Inc.), LEO Pharma A/S, Michelson Diagnostics Ltd., Novartis International AG, and Valeant Pharmaceuticals International, Inc.
The global dermatology diagnostic devices and therapeutics market has been segmented as follows:
Dermatology Diagnostic Devices Market, by Products
Microscopes and Trichoscopes
Dermatology Therapeutics Market, by Drug Class
Dermatology Therapeutics Market: Pipeline Overview, Phase 1, 2, and 3
Tabular Representation: Phase 1 and Phase 2 Candidates
Pipeline Analysis and Forecast: Phase 3
Dermatology Diagnostic Devices and Therapeutics Market, by Geography
Rest of Europe
Asia Pacific (APAC)
Rest of Asia Pacific
Rest of Latin America
Middle East & North Africa (MENA)
Rest of MENA
Rest of the World (RoW)
Read the full report: http://www.reportlinker.com/p03999368-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.